John Mao

Phase I Study of the Intravenous Administration of Attenuated<i>Salmonella typhimurium</i>to Patients With Metastatic Melanoma

John Toso, Vee J. Gill, Patrick Hwu et al. · Journal of Clinical Oncology · 2002 · 670 citations

Intravenous Administration, Immunology, Pathology +18

Synthesis and Pharmacokinetics of Valopicitabine (NM283), an Efficient Prodrug of the Potent Anti-HCV Agent 2‘-<i>C</i>-Methylcytidine

Claire Pierra, Agnès Amador, S. Benzaria et al. · Journal of Medicinal Chemistry · 2006 · 188 citations · Full text

Phase I and pharmacokinetic study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) using a single intravenous dose schedule

Lynn G. Feun, Manuel Modiano, King Lee et al. · Cancer Chemotherapy and Pharmacology · 2002 · 118 citations

Pharmacological Study, 3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone, Pharmacology +5

Tumor-Targeted <i>Salmonella</i> Expressing Cytosine Deaminase as an Anticancer Agent

Ivan King, David Bermudes, Stanley L. Lin et al. · Human Gene Therapy · 2002 · 117 citations

Safety, tolerability and pharmacodynamics of a skeletal muscle activator in amyotrophic lateral sclerosis

Jeremy M. Shefner, Jesse M. Cedarbaum, Merit Cudkowicz et al. · Amyotrophic Lateral Sclerosis · 2012 · 39 citations

Neurological Disorder, Pharmacotherapy, Skeletal Muscle Activator +25